Why do patients with erectile dysfunction abandon effective therapy with sildenafil (Viagra®)?
- 17 June 2004
- journal article
- Published by Springer Nature in International Journal Of Impotence Research
- Vol. 17 (1) , 2-4
- https://doi.org/10.1038/sj.ijir.3901252
Abstract
This prospective study determined the rate of abandonment of sildenafil therapy and assessed the reasons for abandonment. Between January 2001 and December 2002, 234 patients with erectile dysfunction (ED) at three independent centers successfully began therapy with sildenafil 50 or 100 mg. The rate of noncompliance was 31%. A telephone survey of these patients was conducted to determine the reasons for abandonment. The majority reported that they had had no opportunity or desire for sexual intercourse or that their partners had shown no sexual interest. Few patients stated that the high cost of the medication or that adverse events were the cause.Keywords
This publication has 9 references indexed in Scilit:
- Overview of phosphodiesterase 5 inhibition in erectile dysfunctionPublished by Elsevier ,2003
- Phosphodiesterase type 5 inhibitors: a biochemical and clinical correlation surveyInternational Journal Of Impotence Research, 2003
- Attitudes toward treatment of erectile dysfunction: Results from the males studyEuropean Urology Supplements, 2003
- ‘Viagra® Effect’ – Influence of Mass Media on Patient BehaviorUrologia Internationalis, 2001
- Epidemiology of erectile dysfunction: results of the ‘Cologne Male Survey’International Journal Of Impotence Research, 2000
- The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequencesBJU International, 1999
- Sexual Dysfunction in the United StatesJAMA, 1999
- ImpotenceJAMA, 1993
- NIH Consensus Conference. Impotence. NIH Consensus Development Panel on ImpotenceJAMA, 1993